296 related articles for article (PubMed ID: 31404860)
1. Development of novel theranostic agents for in vivo amyloid imaging and protective effects on human neuroblastoma cells.
Li Y; Yan L; Cai J; Zhang W; Li L; Du Z; Dong C; Meunier B; Chen H
Eur J Med Chem; 2019 Nov; 181():111585. PubMed ID: 31404860
[TBL] [Abstract][Full Text] [Related]
2. A theranostic agent for in vivo near-infrared imaging of β-amyloid species and inhibition of β-amyloid aggregation.
Li Y; Xu D; Ho SL; Li HW; Yang R; Wong MS
Biomaterials; 2016 Jul; 94():84-92. PubMed ID: 27107167
[TBL] [Abstract][Full Text] [Related]
3. Development of Phenothiazine-Based Theranostic Compounds That Act Both as Inhibitors of β-Amyloid Aggregation and as Imaging Probes for Amyloid Plaques in Alzheimer's Disease.
Dao P; Ye F; Liu Y; Du ZY; Zhang K; Dong CZ; Meunier B; Chen H
ACS Chem Neurosci; 2017 Apr; 8(4):798-806. PubMed ID: 28097868
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
5. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-β oligomer targeted theranostic probes for in vivo NIR imaging and inhibition of self-aggregation and amyloid-β induced ROS generation.
Wang X; Wang C; Chan HN; Ashok I; Krishnamoorthi SK; Li M; Li HW; Wong MS
Talanta; 2021 Mar; 224():121830. PubMed ID: 33379048
[TBL] [Abstract][Full Text] [Related]
7. Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease.
Brody DL; Jiang H; Wildburger N; Esparza TJ
Alzheimers Res Ther; 2017 Aug; 9(1):62. PubMed ID: 28818091
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent Dopamine-Tryptophan Nanocomposites as Dual-Imaging and Antiaggregation Agents: New Generation of Amyloid Theranostics with Trimeric Effects.
Sharma M; Tiwari V; Shukla S; Panda JJ
ACS Appl Mater Interfaces; 2020 Sep; 12(39):44180-44194. PubMed ID: 32870652
[TBL] [Abstract][Full Text] [Related]
9. [Enalaprilat Inhibits Zinc-Dependent Oligomerization of Metal-Binding Domain of Amyloid-beta Isoforms and Protects Human Neuroblastoma Cells from Toxic Action of these Isoforms].
Kozin SA; Polshakov VI; Mezentsev YV; Ivanov AS; Zhokhov SS; Yurinskaya MM; Vinokurov MG; Makarov AA; Mitkevich VA
Mol Biol (Mosk); 2018; 52(4):683-691. PubMed ID: 30113034
[TBL] [Abstract][Full Text] [Related]
10. Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease.
Wang B; Shi J; Guo N; Shao L; Zhai W; Jiang L; Zhao F; Wang J; Wang J; Du L; Pang X; Yan L
Anal Chim Acta; 2023 Nov; 1281():341900. PubMed ID: 38783740
[TBL] [Abstract][Full Text] [Related]
11. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
Du Z; Li M; Ren J; Qu X
Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820
[TBL] [Abstract][Full Text] [Related]
12. Silibinin: a novel inhibitor of Aβ aggregation.
Yin F; Liu J; Ji X; Wang Y; Zidichouski J; Zhang J
Neurochem Int; 2011 Feb; 58(3):399-403. PubMed ID: 21185897
[TBL] [Abstract][Full Text] [Related]
13. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
[TBL] [Abstract][Full Text] [Related]
14. Coassembled Chitosan-Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer's β-Amyloid.
Wang W; Liu M; Gao W; Sun Y; Dong X
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55879-55889. PubMed ID: 34786930
[TBL] [Abstract][Full Text] [Related]
15. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
16. Aβ oligomers trigger and accelerate Aβ seeding.
Katzmarski N; Ziegler-Waldkirch S; Scheffler N; Witt C; Abou-Ajram C; Nuscher B; Prinz M; Haass C; Meyer-Luehmann M
Brain Pathol; 2020 Jan; 30(1):36-45. PubMed ID: 31099449
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation.
Kochi A; Lee HJ; Vithanarachchi SM; Padmini V; Allen MJ; Lim MH
Curr Alzheimer Res; 2015; 12(5):415-23. PubMed ID: 25938870
[TBL] [Abstract][Full Text] [Related]
18. K114 inhibits A-beta aggregation and inflammation in vitro and in vivo in AD/Tg mice.
Zhang YH; Mann D; Raymick J; Sarkar S; Paule MG; Lahiri DK; Dumas M; Bell-Cohen A; Schmued LC
Curr Alzheimer Res; 2014 Mar; 11(3):299-308. PubMed ID: 24552157
[TBL] [Abstract][Full Text] [Related]
19. Versatile fluorescent probes for near-infrared imaging of amyloid-β species in Alzheimer's disease mouse model.
Peng C; Wang X; Li Y; Li HW; Wong MS
J Mater Chem B; 2019 Mar; 7(12):1986-1995. PubMed ID: 32254802
[TBL] [Abstract][Full Text] [Related]
20. A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
Segal-Gavish H; Danino O; Barhum Y; Ben-Zur T; Shai E; Varon D; Offen D; Fischer B
J Alzheimers Dis; 2017; 58(2):389-400. PubMed ID: 28453480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
